31 March 2015

Liberia: U.S.-Liberia Team Plans Study of Ebola Survivors

The Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) a Liberia -U. S. research team, plans to launch a natural history study of Ebola survivors to better understand the after-effects of Ebola virus disease.

Four sites in Monrovia and locations in the United States may begin enrollment into this study in the coming months.

The study is pending regulatory review and approval, according to statement issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH).

NIAID conducts and supports research at NIH, throughout the United States, and worldwide, to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses.

PREVAIL is currently conducting trials of two experimental Ebola vaccines in Liberia with more than 600 people in Liberia participating in the first stage and about 1,500 volunteers are expected to enroll in Phase Two.

The trial, which began on February 2, 2015 in Monrovia, is testing the safety and efficacy of the cAd3-EBOZ candidate vaccine co-developed by NIAID scientists and GlaxoSmithKline, and the VSV-ZEBOV candidate vaccine developed by the Public Health Agency of Canada and licensed to NewLink Genetics Corporation and Merck.

LINA

Liberia

President Sirleaf Extols Grand Kru Citizens

President Ellen Johnson Sirleaf has extolled citizens of Grand Kru County for the support and patriotism demonstrated in… Read more »

Copyright © 2015 Liberia News Agency. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 700 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.